Skip to content
  • Saturday, 22 August 2026
  • 7:52 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Immature Neurons and the Secret to Cognitive Resilience: New Research Explains Why Some Brains Resist Alzheimer’s Disease
Neuroscience & Brain Research

Immature Neurons and the Secret to Cognitive Resilience: New Research Explains Why Some Brains Resist Alzheimer’s Disease

Rifan Muazin Jul 16, 2026 0

The scientific community has long grappled with a biological paradox: why do some individuals maintain perfect mental clarity until the…

Read More
Neuroscience & Brain Research

Immature Neurons and the Mystery of Cognitive Resilience: New Insights into Why Some Alzheimer’s Brains Remain Mentally Sharp

Rifan Muazin Jul 5, 2026 0

The landscape of Alzheimer’s disease research is undergoing a fundamental shift, moving away from a singular focus on the mechanisms…

Read More
Biogen Acquires Apellis Pharmaceuticals for $5.6 Billion to Bolster Immunology and Rare Disease PortfolioScientists “bottle the sun” with a liquid battery that stores solar energyScientists Develop High Potency Vitamin K Analogues to Drive Brain Cell Regeneration in Neurodegenerative Disease ResearchA Revolutionary Tongue Swab Test Promises to Transform Tuberculosis Diagnosis, Offering Hope to Millions
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ